secwatch.observer — SEC 8-K summary
======================================

Issuer:     Pyxis Oncology, Inc. (PYXS)
CIK:        0001782223
Form:       8-K
Filed at:   2025-06-18T23:59:59+00:00
Accession:  0000950170-25-087907
Event type: other
Sentiment:  neutral
Materiality: 0.15
Item codes: 5.07
LLM model:  deepseek-v4-flash:cloud@v2

Pyxis Oncology annual meeting elects three directors, ratifies EY auditor
-------------------------------------------------------------------------

- Elected Dr. Santhosh Palani, Darren Cline, and Dr. Rachel Humphrey as Class I directors until 2028.
- Palani received 22,056,449 For, 7,314,363 Withheld; Cline: 22,028,914 For, 7,341,898 Withheld; Humphrey: 21,357,102 For, 8,013,710 Withheld.
- Ratified Ernst & Young as independent auditor for FY2025: 43,733,259 For, 233,563 Against, 29,628 Abstain.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1782223/000095017025087907/0000950170-25-087907-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1782223/000095017025087907/pyxs-20250618.htm
  HTML page:      https://secwatch.observer/filing/0000950170-25-087907

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer